Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Clonazepam → 5-(2-chlorophenyl)-2-[bis(morpholino)phosphinyloxy]-7-nitro-3H-1,4-benzodiazepine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Clonazepam | HCID 2802 | — |
| 반응물 | Sodium hydride | HCID 24758 | — |
| 반응물 | Hydride | HCID 166653 | — |
| 반응물 | Bis(morpholino)phosphinyl chloride | HCID 12506606 | — |
| 반응물 | HCID 178418361 | HCID 178418361 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | 5-(2-chlorophenyl)-2-[bis(morpholino)phosphinyloxy]-7-nitro-3H-1,4-benzodiazepine | HCID 20142991 | — |
반응 단계
To a stirred solution of 4.74 g (15 mmoles) of 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one in 80 ml of dry tetrahydrofuran at room temperature was added 875 mg of a 50% dispersion of sodium hydride in oil (18 mmoles of hydride). The mixtute was stirred at room temperature for 1 hr until hydrogen evolution stopped. Dimorpholinophosphinic chloride (7.5 g, 30 mmoles) was added and the resulting mixture was stirred at room temperature for 3 hrs. Solids (mixture of product and salt) were collected and partitioned between water and methylene chloride. The methylene chloride layer was dried and evaporated. Crystallization of the residue from methylene chloride ether gave colorless needles, mp 214°-216°.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US04739049 |
| 출처 데이터셋 | uspto-grants-1988_04 |
| ORD ID | ord-455a76d780e64a069b13066b8c593c22 |
| 출처 메모 | uspto-grants-1988_04 |